Farmers & Merchants Trust Co of Chambersburg PA - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Farmers & Merchants Trust Co of Chambersburg PA ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40.0%5000.0%0.00%0.0%
Q2 2023$40.0%5000.0%0.00%0.0%
Q1 2023$4
-33.3%
5000.0%0.00%
-25.0%
Q4 2022$6
-99.9%
5000.0%0.00%
-20.0%
Q3 2022$6,000
+20.0%
5000.0%0.01%
+25.0%
Q2 2022$5,000
-37.5%
5000.0%0.00%
-20.0%
Q1 2022$8,000
+14.3%
5000.0%0.01%0.0%
Q4 2021$7,0000.0%5000.0%0.01%0.0%
Q3 2021$7,000
-12.5%
5000.0%0.01%
-16.7%
Q2 2021$8,000
+60.0%
5000.0%0.01%
+50.0%
Q1 2021$5,000
+25.0%
5000.0%0.00%
+33.3%
Q4 2020$4,000
+100.0%
5000.0%0.00%
+50.0%
Q3 2020$2,0000.0%5000.0%0.00%0.0%
Q2 2020$2,000
+100.0%
5000.0%0.00%
+100.0%
Q1 2020$1,000
-50.0%
5000.0%0.00%
-50.0%
Q4 2019$2,000
+100.0%
5000.0%0.00%
+100.0%
Q3 2019$1,000
-50.0%
5000.0%0.00%
-50.0%
Q2 2019$2,000
-50.0%
5000.0%0.00%
-33.3%
Q1 2019$4,0000.0%5000.0%0.00%
-25.0%
Q4 2018$4,0000.0%5000.0%0.00%
+33.3%
Q3 2018$4,000
+33.3%
5000.0%0.00%0.0%
Q2 2018$3,000
-99.9%
5000.0%0.00%
+50.0%
Q1 2018$2,385,000
-2.9%
5000.0%0.00%0.0%
Q4 2017$2,455,000
-6.3%
5000.0%0.00%0.0%
Q3 2017$2,620,000
-5.8%
5000.0%0.00%0.0%
Q2 2017$2,780,000
-33.8%
5000.0%0.00%
-50.0%
Q1 2017$4,200,000
+32.7%
5000.0%0.00%
+33.3%
Q4 2016$3,165,0005000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders